Terumo News

Terumo Corporation, established in 1921 and based in Tokyo, Japan, is a global leader in medical technology. The company offers a wide range of products and services, including vascular intervention, cardio-surgical solutions, blood transfusion, cell therapy technologies, and clinical essentials. Terumo is committed to contributing to society through healthcare, emphasizing innovation, quality, and sustainability. With over 30,000 associates worldwide, Terumo provides innovative medical solutions in more than 160 countries and regions.

www.terumo.com

03 JUL '25

Written on {{ "2025-07-03T00:00:00+00:00" | date "longDate" }}

Terumo launches IMMUCISE intradermal injection system commercially worldwide

The Immucise system enables precise vertical intradermal injections with a 1.15mm needle, FDA-approved and CE-marked for use in patients aged 2 months and older.

Read more…

20 JUN '25

Written on {{ "2025-06-20T00:00:00+00:00" | date "longDate" }}

Terumo and MedHub-AI partner to market AI-based FFR in Japan

An AI-Driven AutocathFFR Enables Faster, Safer, and More Accurate Coronary Artery Disease Assessment Without Invasive Procedures or Pharmacological Stress Agents.

Read more…

28 JAN '25

Written on {{ "2025-01-28T00:00:00+00:00" | date "longDate" }}

Terumo BCT and FUJIFILM Irvine Scientific to Accelerate T Cell Expansion for Cell Therapy Developers

Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV T Cell Expansion Media on Terumo BCT’s Quantum Flex Cell Expansion System, easing the burden for developers.

Read more…

31 OCT '24

Written on {{ "2024-10-31T00:00:00+00:00" | date "longDate" }}

Terumo Blood & Cell Technologies advances automated manufacturing for novel cell & gene therapies

The company is starting in Brazil, Colombia and Mexico, seeking to improve efficiency and cost-effectiveness in the manufacturing process for companies in the region.

Read more…

21 OCT '24

Written on {{ "2024-10-21T00:00:00+00:00" | date "longDate" }}

TERUMO BCT KICKS OFF U.S. LAUNCH OF REVEOS AUTOMATED BLOOD PROCESSING SYSTEM

Reveos is the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle.

Read more…

28 JUN '24

Written on {{ "2024-06-28T00:00:00+00:00" | date "longDate" }}

TERUMO: MICROVENTION’S LVIS™ EVO™ INTRALUMINAL SUPPORT DEVICE NOW AVAILABLE IN THE US

MicroVention Continues to Lead the Way in Innovation for both Ischemic and Hemorrhagic Stroke Treatment and Prevention.

Read more…

22 MAR '24

Written on {{ "2024-03-22T00:00:00+00:00" | date "longDate" }}

TERUMO BCT PARTNERS WITH CIRA FOUNDATION TO DEVELOP AUTOMATED IPS CELL MANUFACTURING

iPS cell manufacturing organization researchers will integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration.

Read more…

13 DEC '23

Written on {{ "2023-12-13T00:00:00+00:00" | date "longDate" }}

TERUMO LAUNCHES NEW AZUR HYDROPACK™ PERIPHERAL COIL SYSTEM

The new AZUR HydroPack™ Peripheral Coil System provides a soft-packing, long-lasting solution to embolotherapy.

Read more…

02 AUG '23

Written on {{ "2023-08-02T00:00:00+00:00" | date "longDate" }}

REVEOS^® AUTOMATED WHOLE BLOOD PROCESSING SYSTEM CLEARED BY FDA FOR U.S. COMMERCIAL USE

Terumo Blood and Cell Technologies' Reveos is positioned to help U.S. blood centres supplement the platelet supply, reduce labour and costs, and improve overall operational efficiency.

Read more…